Dr. Gor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Bowman Drive
Suite E125
Voorhees, NJ 08043Phone+1 856-424-3311
Summary
- Dr. Priya Gor is an oncologist in Voorhees, NJ and is affiliated with multiple hospitals in the area, including Virtua Voorhees, Virtua Our Lady of Lourdes Hospital, Virtua Marlton, and Penn Presbyterian Medical Center. She received her medical degree from Rutgers Robert Wood Johnson Medical School, completed her residency in internal medicine and fellowship in hematology/oncology at the Hospital of the University of Pennsylvania. She has been in practice 20 years. Dr. Gor specializes in breast cancer.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2003 - 2006- University of Pennsylvania Health SystemResidency, Internal Medicine, 2000 - 2003
Rutgers Robert Wood Johnson Medical SchoolClass of 2000
Certifications & Licensure
NJ State Medical License 2007 - 2025
PA State Medical License 2003 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Interpreting quantitative RNA expression prognostic and predictive results generated from synchronous rather than solitary breast cancers.Steven Sorscher, Priya Gor
Biomarkers. 2024-05-01 - 51 citationsCyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort studyPriya P Gor, H. Irene Su, Robert Gray, Phyllis A. Gimotty, Michelle Horn
Breast Cancer Research. 2010-05-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
